Pembrolizumab Combined with Chemotherapy for the Treatment of locally Advanced Esophageal Cancer

被引:0
作者
Han, KaiHong [1 ]
Xie, ShaoNan [1 ]
Liu, QingYi [1 ]
Cheng, JingGe [1 ]
Han, YaQing [1 ]
机构
[1] Hebei Med Univ, Dept Thorac Surg, Hosp 4, 12 Jiankang Rd, Shijiazhuang, Hebei Province, Peoples R China
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2023年 / 42卷
关键词
esophageal cancer; locally advanced; neoadjuvant therapy; PD-1; inhibitor; pembrolizumab; SQUAMOUS-CELL CARCINOMA; NEOADJUVANT CHEMORADIOTHERAPY; NIVOLUMAB; SURGERY; RADIOSENSITIVITY; MICROENVIRONMENT; CHEMORADIATION; IMMUNOTHERAPY; RADIOTHERAPY; IPILIMUMAB;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to evaluate the safety and efficacy of Pembrolizumab combined with chemotherapy in neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma. Patients with locally advanced esophageal squamous cell carcinoma who underwent neoadjuvant therapy in our department from October 2021 to September 2022 were selected. They received two cycles of chemotherapy combined with Pembrolizumab before surgery. A total of 32 patients were enrolled, 29 patients subsequently underwent surgery, the pCR rate was 27.6% (8/29). Patients with a positive CPS score had a higher probability of pCR (46.2% vs. 12.5%, p < 0.05). CD8+ cell rate increased after neoadjuvant therapy, and the difference was statistically significant compared to before treatment (p < 0.001).The clinical efficacy of immune checkpoint inhibitors combined with chemotherapy for neoadjuvant therapy in patients with advanced esophageal squamous cell carcinoma is definite, and the safety and feasibility are high.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [21] Pretreatment Esophageal Wall Thickness Associated with Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer
    Wongwaiyut, Kraipop
    Ruangsin, Sakchai
    Laohawiriyakamol, Supparerk
    Leelakiatpaiboon, Siriporn
    Sangthawan, Duangjai
    Sunpaweravong, Patrapim
    Sunpaweravong, Somkiat
    [J]. JOURNAL OF GASTROINTESTINAL CANCER, 2020, 51 (03) : 947 - 951
  • [22] Treatment strategies for elderly patients with locally advanced esophageal cancer: a systematic review and meta-analysis
    Yao, Jiacheng
    Zhao, Xinyu
    Chen, Jun
    Liu, Tingting
    Song, Yaowen
    Dang, Jun
    [J]. BMC CANCER, 2024, 24 (01)
  • [23] Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer
    Mayanagi, Shuhei
    Irino, Tomoyuki
    Kawakubo, Hirofumi
    Kitagawa, Yuko
    [J]. ANNALS OF GASTROENTEROLOGICAL SURGERY, 2019, 3 (03): : 269 - 275
  • [24] Induction Chemotherapy for Locally Advanced Esophageal Cancer
    Harada, Guilherme
    da Cunha Colombo Bonadio, Renata Rodrigues
    Cordeiro de Araujo, Frederico Cantarino
    Victor, Carolina Ribeiro
    Aissar Sallum, Rubens Antonio
    Ribeiro Junior, Ulysses
    Cecconello, Ivan
    Takeda, Flavio Roberto
    de Castria, Tiago Biachi
    [J]. JOURNAL OF GASTROINTESTINAL CANCER, 2020, 51 (02) : 498 - 505
  • [25] Induction Chemotherapy for Locally Advanced Esophageal Cancer
    Guilherme Harada
    Renata Rodrigues da Cunha Colombo Bonadio
    Frederico Cantarino Cordeiro de Araújo
    Carolina Ribeiro Victor
    Rubens Antonio Aissar Sallum
    Ulysses Ribeiro Junior
    Ivan Cecconello
    Flávio Roberto Takeda
    Tiago Biachi de Castria
    [J]. Journal of Gastrointestinal Cancer, 2020, 51 : 498 - 505
  • [26] Pembrolizumab for first-line treatment of advanced unresectable or metastatic esophageal or gastroesophageal junction cancer
    Hirose, Toshiharu
    Yamamoto, Shun
    Kato, Ken
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [27] Multidisciplinary Management of Early and Locally Advanced Esophageal Cancer
    Kaifi, Jussuf T.
    Gusani, Niraj J.
    Jiang, Yixing
    Mackley, Heath B.
    Dye, Charles E.
    Mathew, Abraham
    Kimchi, Eric T.
    Reed, Michael F.
    Staveley-O'Carroll, Kevin F.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (05) : 391 - 399
  • [28] Long-term efficacy and predictors of pembrolizumab-based regimens in patients with advanced esophageal cancer in the real world
    Wang, Hong-Chi
    Huang, Xiang
    Chen, Jing
    Li, Ye
    Cong, Yang
    Qu, Bao-Lin
    Feng, Sheng-Qiang
    Liu, Fang
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (41) : 5641 - 5656
  • [29] Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab compared with chemotherapy alone and chemoradiotherapy for locally advanced esophageal squamous cell cancer
    Zhang, Baihua
    Zhao, Hongbo
    Wu, Xun
    Gong, Lianghui
    Yang, Desong
    Li, Xu
    Chen, Xiaoyan
    Li, Jigang
    Wang, Wenxiang
    Wu, Jie
    Xiao, Qin
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer
    Kato, Ken
    Shah, Manish A.
    Enzinger, Peter
    Bennouna, Jaafar
    Shen, Lin
    Adenis, Antoine
    Sun, Jong-Mu
    Cho, Byoung Chul
    Ozguroglu, Mustafa
    Kojima, Takashi
    Kostorov, Vladimir
    Hierro, Cinta
    Zhu, Ying
    McLean, Lee Anne
    Shah, Sukrut
    Doi, Toshihiko
    [J]. FUTURE ONCOLOGY, 2019, 15 (10) : 1057 - 1066